About LabGenius
LabGenius is a company based in London (United Kingdom) founded in 2012 by Leila Rastegar Zegna and James Field. It operates as a B2B. The company has 54 employees as of January 31, 2022. LabGenius offers products and services including EVA™ Platform. LabGenius operates in a competitive market with competitors including AbSci, Antiverse, Ordaos, Orbit Discovery and immunitoAI, among others.
- Headquarter London, United Kingdom
- Employees 54 as on 31 Jan, 2022
- Founders Leila Rastegar Zegna, James Field
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Labgenius Limited
- Date of Incorporation 17 Aug, 2012
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
54
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LabGenius
LabGenius offers a comprehensive portfolio of products and services, including EVA™ Platform.
Automated system for rapid identification of therapeutic antibodies.
People of LabGenius
Unlock access to complete
Unlock access to complete
Funding Insights of LabGenius
Detailed funding history for LabGenius
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LabGenius
Investment portfolio details for LabGenius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LabGenius
Detailed financials for LabGenius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Labgenius Comparisons
Peer comparison for LabGenius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LabGenius
LabGenius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, Antiverse, Ordaos, Orbit Discovery and immunitoAI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
An AI platform for antibody drug discovery is provided.
|
|
| Locked | Locked | Locked |
AI accelerator provided for biomedical research and drug discovery.
|
|
| Locked | Locked | Locked |
Drug discovery platform developed using peptide display engine.
|
|
| Locked | Locked | Locked |
An AI-based platform for antibody discovery and therapeutics is developed.
|
Detailed competitors of LabGenius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Labgenius
Complete news archive for LabGenius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LabGenius
LabGenius was founded in 2012.
LabGenius is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
James Field is the current CEO of LabGenius. They have also founded this company.
As of Jan 31, 2022, the latest employee count at LabGenius is 54.
LabGenius Therapeutics develops therapeutic antibodies using AI and machine intelligence through the EVA platform, which automates discovery and co-optimization of complex molecules. The company focuses on selectivity-enhanced antibodies for solid tumours, combining human expertise with technology. Based in London, UK, it advances internal pipelines and potential partnerships in biotechnology.
LabGenius offers EVA™ Platform.